Clinical Trial Update: A Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating tolerance, safety, and pharmacokinetics of GNR-055 in healthy volunteers has completed; the study is associated with mucopolysaccharido…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Diseases
• Mucopolysaccharidosis Type Ii

Drugs mentioned

• GNR-055 (GNR-055)

Snippet

Sponsor: AO GENERIUM | Conditions: Mucopolysaccharidosis Type II, Metabolic Diseases | Phase 1 | Status: COMPLETED